Press Releases

Immudex launches dCODE Dextramer® (RiO), a new reagent compatible with BD Rhapsody™ Single Cell Analysis system

Immudex ApS, the sole proprietor of DNA barcoded MHC multimer technology, has announced the launch of dCODE Dextramer® (RiO) — a new reagent compatible with BD Rhapsody™ Single Cell Analysis system for multiplexing, allowing the identification of many different T-cell specificities in the same sample. Creating personalized dCODE Dextramer® libraries, is possible to profile T cells and get a new understanding of T-cell immunity.

VERICHEM LABORATORIES EXPANDS REPORT OPTIONS FOR ITS FREE CLIA COMPLIANT CALIBRATION VERIFICATION PROGRAM

VERICHEM LABORATORIES has announced that it has expanded the available test reporting options that it offers with its Calibration Verification Data Reduction Program.

Albumedix enters into collaboration agreement with Cell and Gene Therapy Catapult

Albumedix Ltd., the world leader in recombinant human albumin, has entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult), an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.

Bio-Rad’s Multi-Target Reliance SARS-CoV-2/FluA/FluB RT-PCR and Reliance SARS-CoV-2 RT-PCR Assay Kits Granted FDA Emergency Use Authorization

Bio-Rad Laboratories, Inc. announced that its Reliance SARS-CoV-2/FluA/FluB RT-PCR and Reliance SARS-CoV-2 RT-PCR Assay Kits were granted Emergency Use Authorization by the U.S. Food and Drug Administration.

BioIVT Unveils COVID-19 Panel to Accelerate Vaccine-generated Immune Response Research

The panel contains serum or peripheral blood mononuclear cells (PBMCs) isolated from pre- and post-vaccination blood samples.

Lonza Announces High-Quality Cryopreserved Leukopaks for More Flexibility in Immunology and Cell Therapy Research

Lonza has expanded its renowned human primary cell offerings with the launch of fully customizable, high-quality cryopreserved Leukopaks to biopharmaceutical researchers across the globe. The frozen Leukopaks will enable long-distance shipping of leukapheresis products without the concern of reduced cell viability encountered with fresh Leukopaks, and will eliminate the risk and costs associated with donor cancellations or changes to experimental schedules.

ENPICOM introduces an end-to-end solution for fast and efficient antibody discovery

ENPICOM BV, an innovative bioinformatics software engineering company, has announced the release of its ImmunoGenomiX (IGX) Platform featuring the new Antibody Discovery Module. The IGX Platform is a professional tool to manage, analyze, integrate, and visualize immune repertoire sequencing data in a single environment. This solution will allow scientists in biopharmaceutical companies and academia, as well as service providers working in the antibody discovery field, to make the most of their Sanger and NGS data and independently perform complex analyses.

Lifeasible Developed Thermal Analysis Platform for Material Research

Matexcel Introduced Mechanical Environment Reliability Test Worldwide

Alfa Chemistry Recently Launched a Sub-website for Functional Polymers

Alfa Chemistry Launches MOF Chemicals for the Science Community

Syntekabio and Hanmi Science Join Forces to Co-Develop New Promising COVID-19 Treatments Using Drug Repurposing Technologies

Syntekabio has announced a strategic collaboration with Hanmi Science to co-develop breakthrough COVID-19 treatments using drug repositioning technologies.

MedAI Launches Artificial Intelligence Drug Discovery (AIDD) Platform to Accelerate Drug Development

To accelerate drug development, MedAI, an expert of AI-assisted R&D research company, announces that it has completed the construction of its Artificial Intelligence Drug Discovery (AIDD) Platform. With this platform, scientists at MedAI are now capable of providing innovative solutions for pharmaceutical companies to push forward their drug discovery projects.

eNUVIO is Launching the OMEGA-96 Device

Today, eNUVIO has announced the launch of their latest innovative microfluidic device for neuronal compartmentalization and co-culture experiments — the OMEGA-96. This first of its kind microplate will help to improve the success and efficiency of drug discovery and safety toxicology in neurological research areas, particularly in the field of neurodegenerative and neuromuscular diseases.

Alfa Chemistry Provides Wide Choices of Pyridinium Ionic Liquids for Scientific Research

Pyridinium ionic liquids are widely applied in Diels-Alder reaction, Friedel-Crafts reaction, Suzuki reaction, Grignard Reaction as well as the synthesis of some pharmaceutical agents. To meet the growing needs for this type of chemicals, Alfa Chemistry recently announced to provide wide choices of pyridinium ionic liquids for clients both at home and abroad. Most of them are in stock and can be delivered to buyers within a few business days.

Shimmer’s Verisense® Wearable Sensing Platform Selected for Boston University Brain Health Studies

These studies, which are funded by the American Heart Association, will use wearable sensors to increase knowledge of the links between brain and heart health.

‘UK government can deliver Brexit benefit with world’s best medicines security’ say FarmaTrust

Company forewarns the UK is risking fake COVID-19 vaccines and other medicines without a new system

Ubiquigent and the University of York Awarded a Grant to Explore the Potential of Deubiquitylase (DUB) Enzyme Inhibitors to Address Neglected Tropical Diseases

Ubiquigent today announced a collaboration with Mottram Laboratory at the University of York to investigate the inhibition of deubiquitylase (DUB) enzymes expressed by the protozoan Leishmania mexicana for the treatment of leishmaniasis.

Alfa Chemistry: Instrumental Analytical Reagents Are Now Accessible

Alfa Chemistry announced in a statement that the company starts to provide varieties of instrumental analytical reagents for consumers worldwide. In addition to other reagents that are previously released, now the company’s supply range of products are widely broadened, which encompasses: chromatography standards and derivatization reagents, Ion Sensor Materials, Laboratory Supplies, LPLC/TLC/Paper Chromatography, and Titration.

Thermo Fisher Scientific Releases SARS-CoV-2 Optimized Precipitation Reagent* and Enrichment Kits* for Isolating Virus Particles

Thermo Fisher just introduced the new Invitrogen Intact Virus Precipitation Reagent and Dynabeads Intact Virus Enrichment Kits, which are optimized to isolate intact SARS-CoV-2 virus particles to support viral research.